We have known for over a year that the FFB cannot get involved unless the MA09 cell line is NIH approved for federally funded monies. That is nothing new and NIH approval doesn't seem very close at this juncture.
Published: February 19, 2010 "As a private company, Advanced Cell itself is not bound by N.I.H. rules, but its clinical trial, to be conducted with the Foundation Fighting Blindness, will be supported by the Department of Defense, so the institutes’ approval of the cells is required, Dr. Lanza said." http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46863846
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.